Charles Pauling Semba - 23 Jun 2023 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Issuer symbol
DMAC
Transactions as of
23 Jun 2023
Net transactions value
+$49,997
Form type
4
Filing time
26 Jun 2023, 16:26:41 UTC
Previous filing
02 Jun 2023
Next filing
02 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMAC Voting Common Shares, no par value per share Purchase $49,997 +12,787 +75% $3.91 29,943 23 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 12,867 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.